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ABSTRACT 
 
TITLE: A comparison of smokeless tobacco usage in two NCAA baseball programs 
 
INTRODUCTION:  Smokeless tobacco (ST) is commonly associated with baseball. 
  The purpose of this paper is to examine and compare the ST usage patterns on an 
NCAA Division I baseball team and an NCAA Division III baseball team.  The collected 
data will be compared to patterns of use from similar age groups in a national survey. The 
health effects of ST will be examined, along with the background of ST and baseball.  
 
METHODS: An online survey was used to distribute and administer the questionnaire to 
willing participants on the two college baseball teams.  The survey was open from 
October 29th, 2013 to February 1st, 2014, at which point the data was collected and 
analyzed for patterns of use in SPSS. The results were then compared to smokeless 
tobacco use rates in baseball players and student-athletes on the whole found by the 
NCAA Student-Athlete Substance Abuse Surveys from 1997, 2001, and 2009.     
 
RESULTS:  The NCAA Division I baseball team had substantially higher rates of use, 
both in terms of ever-use and habitual use when compared to the NCAA Division III 
baseball team.  On the Division I team, 75% of players reported ever-use and 62.5% of 
players reported habitual use.  On the Division III team, 35.7% of players reported ever-
use, while only 14.3% of players reported habitual use.   
 
DISCUSSION:     The survey found that the Division I team reported higher rates of use 
than the Division III team, other NCAA student-athletes generally (75% ST ever-use and 
62.5% habitual ST use compared to 17.4% of other student-athletes reporting past 12 
month ST use) and higher use than other NCAA baseball players (75% ST ever-use and 
62.5% habitual ST use compared to 52.3% of other NCAA baseball players reporting 
past 12 month ST use),while the Division III team only reported only higher ever-use 
than NCAA student-athletes on the whole reported use in the last 12 months, (35.7% 
compared to 17.4%).  The Division III team reported quite a bit less use than other 
NCAA baseball players (35.7% ST ever-use and 14.3% habitual ST use compared to 
52.3% past 12 month ST use in other NCAA baseball players).  This is an awkward 
comparison given the difference in definitions of use ever-use and habitual use versus 
past 12 month use.   
The major issue with the study was the lack of a large sample size, so the data 
should be used cautiously.  The rates on both teams would likely be closer had more 
players responded to the survey. There was some difficulty in comparing this data with 
the NCAA data given the different operational definitions smokeless tobacco use.  The 
NCAA asked about use in the last 12 months, while this survey asked about ever-use and 
habitual use as determined by regularity and frequency of use.  
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Chapter I 
 
INTRODUCTION 
 
 
1.1 Background 
Smokeless tobacco use has long been associated with baseball in the United 
States; particularly with Major League Baseball (MLB).  The practice has been 
commonplace in the MLB since the 1880s when players used smokeless tobacco to keep 
their mouths moist on the dry, dusty fields of the era (Connolly, Orleans, & Blum, 1992).  
Though ever present, the use of ST increased in the 1970s and 1980s as the risks of 
cigarette smoking became commonly known and ST companies began an aggressive 
marketing campaign targeting professional baseball players (Severson, Klein, 
Liechtenstein, Kaufman, & Orleans, 2005). This association has trickled down to amateur 
levels of baseball, including National Collegiate Athletic Association (NCAA) baseball.   
In the campaign against tobacco use, smokeless tobacco (ST) is often neglected or 
forgotten.  Smokeless tobacco (ST) is any form of tobacco that is consumed without 
combustion.  The two main types are moist snuff and chewing tobacco.  Snuff is finely 
cut or ground tobacco that is usually moist and typically packaged in a can or “tin.”  It 
comes in different types of cut (long cut, fine cut) and a variety of flavors.  While usually 
in loose form, snuff can also be found in the form of pouches with a pre-portioned 
amount inside or in the form of dissolvable lozenges and strips.  Chewing tobacco is 
available as loose leaves, plugs (similar to a brick of tobacco that a users cut pieces off 
for chewing), and twists of rope made of tobacco leaves.  It is either chewed or held in 
place on one side of the mouth, and the excess saliva produced is either spit or swallowed 
(NCI Smokeless Tobacco Fact Sheet, 2010).  It is far more visible than snuff and usually 
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forms the distinctive cheek bulge that is thought of when one thinks of the smokeless 
tobacco baseball players use.   
A newer type of ST called snus has become available in the United States, though 
it has long been available in Scandinavian countries.  It is similar to snuff in that it can be 
moist or dry and comes loose or in small pouches, but is pasteurized and is cured using 
steam or a combination of steam and fire instead of fire alone, which considerably 
reduces the levels of carcinogenic Tobacco-specific N-nitrosamines (TSNAs) present 
(Lee, 2013).  Other types of smokeless tobacco exist elsewhere in the world, such as the 
Sudanese Toombak, Afghani Naswar, and Indian Gutka, and at least statistically, are far 
more carcinogenic and harmful than the types of ST used in baseball.  These types of ST 
often include other additives (industrial lime, betel quid, etc.) that appear to create a 
synergistic carcinogenic effect (Health, 1986).  The types of ST presented here are the ST 
products commercially available in the United States, with the focus being on moist snuff 
and chewing tobacco, the two types of ST used almost exclusively in Major League 
Baseball (MLB) (Boffetta, Hecht, Gray, Gupta, & Straif, 2008, Euromonitor 
International, 2013).   
Smokeless tobacco and baseball have a long and storied history.  Many great 
players were ST users such as Tony Gwynn and Babe Ruth, and many, like Chase Utley, 
Nick Swisher, and Dan Uggla, still are.  Major League Baseball now publicly discourages 
its use and has put restrictions on its use in public in front of fans (autograph signings and 
other public off-field appearances) but this has not stopped professional players from 
continuing to use ST.  Recent estimates of the prevalence of ST use in the MLB have 
approached as high as 40-50%, though these rates do appear to be steadily declining over 
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time (Cooper, Ellison, & Walsh, 2003).  An outright ban on ST in the minor leagues has 
not led to a substantial decrease in ST users in professional baseball either.  Seeing 
professional players use ST has long provided at least some influence on adolescent 
baseball players to begin using; once beginning to use ST these new users can influence 
their peers as well, thus perpetuating the cycle of smokeless tobacco and baseball 
(Connolly, Orleans, & Blum, 1992, Eaves, 2011).  MLB players should remember that 
they are role models to a large number of children, who emulate behaviors of the people 
they look up to.  Hopefully, if enough professional players stop using ST or never start, 
then the behavior will cease to trickle down and over time ST use and baseball will no 
longer be associated with one another. 
 
1.2 Purpose of Study  
 The purpose of this study is to measure and quantify patterns of ST use on an 
NCAA Division I baseball team and an NCAA Division III baseball team, then compare 
the data looking for differences between the two teams.  After this comparison, this data 
will be compared with survey responses from other NCAA student athletes. 
  
1.3 Research Questions 
 How many players use ST on the NCAA Division I baseball team and how many 
players use ST on the NCAA Division III baseball team?  Does one team have more 
ST users proportionately than the other?  What percentage overall of each team uses 
ST? 
 Are NCAA baseball players that play a particular position more likely to use ST? 
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 How do the collected survey results compare to other NCAA athlete survey 
responses?  Do the baseball players on these two teams use ST more or less than 
other NCAA baseball players around the country? 
 How do the ST usage rates from the two surveyed teams compare to NCAA student-
athlete data from years past? 
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Chapter II 
 
REVIEW OF THE LITERATURE 
 
In this chapter, support for this study’s research questions is synthesized from the 
scientific literature.   
 
2.1 Pharmacodynamics of Smokeless Tobacco (ST) 
 ST is any kind of tobacco that is consumed orally without combustion.  The most 
common types available in the US and the two used in (and the types covered by this 
document) include: moist snuff or “dipping tobacco” that comes in finely shredded form 
or in pre-portioned pouches, chewing tobacco, which comes in loose leaf form, plugs (a 
“brick” of tobacco), and braided ropes of tobacco As mentioned above, there are a wide 
variety of other ST products around the world, but this document is limited in scope to 
the two types sold in the continental United States most often used in MLB, moist snuff 
and chewing tobacco (Boffetta, et al., 2008, Cooper, Ellison, & Walsh, 2003).  ST, like 
other forms of tobacco, is highly addictive due to the presence of nicotine.   
Nicotine is specifically classified as a euphoriant that produces dose-dependent 
changes in mood and feeling.  Nicotine, like other addictive drugs, causes perceptible 
neurological changes that are appealing to the user, thus reinforcing the nicotine-
administering behavior, subsequently resulting in addiction.  Over time, nicotine causes 
neuroadaptation that leads to much higher tolerance and severe physiological 
dependence, regardless of the route of nicotine administration.  Users of ST appear to be 
as addicted, if not more addicted, to nicotine than cigarette users.  This is thought to be 
due in part to the proximity of the buccal mucosa to the brain (Health, 1986).   
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Once placed in the mouth, the nicotine from the smokeless tobacco is rapidly 
absorbed into the bloodstream from the buccal mucosa, at levels as much as twice as high 
as after smoking one cigarette (Fant, Henningfield, Nelson, & Pickworth, 1999).  Fant et 
al. (1999) assumed users of ST use approximately 2.5 grams per use, thus it is safe to 
assume that many ST users use portions that differ in size from the doses studied in 
Fant’s et al. controlled conditions.  This means it is possible that more nicotine is 
delivered than in even two cigarettes.  Based on the author’s observations during his 
collegiate baseball career, many users of ST use two or more pouches of ST at once 
instead of only one at a time.   
Nicotine is most easily absorbed in its unionized form, which is PH dependent; as 
PH rises, the unionized nicotine is more readily absorbed by the buccal mucosa.  Thus, 
not only the total nicotine content of a ST product is important, but the PH of the product 
and the proportion of the total nicotine in unionized form are as well.  The PH of ST 
increases the longer it is exposed to saliva, thus increasing the amount of nicotine 
absorbed by the user.  After entering the bloodstream, the nicotine causes an increase in 
heart rate, diastolic blood pressure, and systolic blood pressure.  The increase in heart rate 
ceases or begins to decline after approximately 15 minutes of nicotine absorption (Fant et 
al., 1999). 
Besides nicotine, ST contains a variety of harmful compounds, the most notable 
being Tobacco-specific nitrosamines (TSNAs).  TSNAs form during the curing and 
processing of the tobacco leaves, as well as from the formation of nitrate and nitrite by 
bacteria endemic to tobacco (Rodu & Jansson, 2004).  The TSNAs 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanone (abbreviated to NNK) and N'-
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nitrosonornicotine (NNN) are believed to play a role in the development of a variety of 
tobacco-related cancers, including cancers of the lung, esophagus, oral cavity, and 
pancreas (Hecht, Carmela, Foiles, Murphy, & Peterson, 1993).  Levels of TSNAs in ST 
are unrelated to total nicotine, un-ionized nicotine, moisture, price, or market share 
(Richter, Hodge, Stanfill, Zhang, & Watson, 2008).  Levels of TSNAs have fallen 
considerably since the 1986 Surgeon General’s report, and continue to decrease due to 
improved production, storing, and fermentation methods.  It is interesting to note that 
unlike levels of TSNAs which have decreased over time, nicotine content has remained 
the same or increased since the Surgeon General’s report (Health, 1986, Brunnemann, Qi, 
& Hoffmann, 2002). Whether the reductions in TSNAs will have an observable effect at 
the population level remains to be seen.   
Other harmful compounds include a variety of polycyclic aromatic hydrocarbons 
(PAHs), which after TSNAs are the strongest carcinogens in ST, followed by trace 
amounts of Polonium 210 (
210
Po) (Stepanov et al., 2010).  PAHs are carcinogens formed 
during the tobacco curing process, and traditionally from the incomplete combustion of 
organic matter.  Chemicals classified as PAHs include Benzo[a]pyrene (BaP), 
naphthalene, acenapthylene, anthracene, and fluorene (Stepanov et al., 2010). The 
Polonium, along with other trace amounts of carcinogens like lead, formaldehyde, 
cadmium, and Uranium 235 (
235
U) are thought to be absorbed by the tobacco roots and 
leaves from both the fertilizer and soil used during the growing of the tobacco before 
being processed into ST (Brunnemann & Hoffmann, 1992).   
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2.2 Health Effects of ST 
In addition to the potent carcinogens present in ST, its use causes changes in oral 
anatomical structures at the cellular level.  A 1992 study by Daniels et al. found four 
types of changes in 142 biopsy specimens from 133 professional baseball players that 
were regular ST users.  The four types of changes were hyperparakeratosis, 
hyperorthokeratosis, pale surface staining, and basal cell hyperplasia.  Hyperparakeratosis 
is the more technical term for leukoplakia, a white, premalignant plaque that often forms 
in the mouths of ST users.  Leukoplakia also often presents with hyperorthokeratosis, an 
abnormal thickening of granular keratohyaline cells in the orthokeratin layer of the buccal 
mucosa.  Pale surface staining is a discoloration of the visible enamel on teeth; it usually 
is yellowish or brownish in users of tobacco.  Basal cell hyperplasia is an abnormal 
thickening of basal cells in a given area of epithelium; this is typically in the area of the 
mouth the user places the ST (Daniels et al., 1992).   
While chemical and histological analyses are important, substantial research has 
been done at the population level to determine the strength of the association between ST 
and many varieties of cancer and cardiovascular disease.  Older research (before 1990), 
and research by a subset of specific authors (Boffetta and Winn, for example) have found 
much higher correlations between ST use and cancer than newer studies have.  In the 
oldest studies, this is due, at least in part, to several factors: they often did not have 
control groups, and if they did; there were no attempts to control for confounding 
(Rosenfeld & Callaway, 1963, Landy & White, 1961, Wilkins & Vogler, 1957).   
Once modern epidemiologic methods became standard practice, the accepted 
format of case-control studies and retrospective cohort studies became common for 
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studying the health risks of ST.  In what has been considered the “landmark” study on 
ST, Winn et al. (1981) found a remarkably increased RR for oral cancer in snuff dippers 
in a case-control study done on North Carolina women.  They found that the RR for 
female snuff dippers that were nonsmokers was 4.2 (CI=2.6-6.7), and that among female, 
long-term (>50 years), chronic users, the RR was increased by nearly 50 times.  They 
concluded that non snuff-dipping-related oral cancers resulted from the combination of 
cigarette smoking and alcohol consumption (Winn et al., 1981).  This nearly 50-fold 
relative risk increase has since been generalized to all types of ST, all forms of oral 
cancer, and this statistic became the status quo that has been repeated since. 
Zhou et al. (2013) found a non-significant elevated risk for ever having used ST 
and head and neck Squamous cell carcinoma (HNSCC) (OR 1.2, CI=0.67-2.16).  They 
also found a significant elevated risk for long term (>10 years) users of ST (OR 4.06, 
CI=1.31-12.64).  And most importantly, they found an elevated risk in ever-users of ST 
compared to never cigarette smokers (OR 4.21, CI=1.01-17.57), suggesting that long-
term ST use increases the risk for developing HNSCC and oral cancer (Zhou et al., 2013).  
In another study, Alquacil and Silverman (2004) conducted a case-control study by 
interview with residents of Atlanta, Detroit, and 10 counties in New Jersey.  They found a 
moderately increased risk of pancreatic cancer in subjects that used >2.5 ounces of ST a 
week (OR 3.5, CI=1.1-11), and an increased risk in long-term ST users (OR 1.5, CI=0.6-
4.0), though the latter statistic was non-significant (Alquacil & Silverman, 2004).   
Large retrospective studies have also been done to attempt to quantify the risks of 
ST use.  Bjelke and Schuman (1982) published one of the earliest of the large cohort 
studies; they found that in cohorts of 12,945 Norwegian men and 16,930 American men, 
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there was an increased risk of dying from oral, pharyngeal, and esophageal cancers (RR 
2.6-31, no CI reported), as well as an increased risk of developing pancreatic cancer (RR 
2.9, no CI reported).  Boffetta, Aagnes, Weiderpass, & Andersen (2005) retrospectively 
examined a cohort of 10,136 Norwegian men that used snus and found the relative risk 
(RR) of pancreatic cancer was 1.67 (CI=1.12-2.50), the RR of oral and pharyngeal cancer 
was 1.10 (CI= 0.50-2.41), the RR of esophageal cancer was 1.40 (CI=0.61-3.24), and the 
RR of stomach cancer was 1.11 (CI=0.83-1.48).  Luo et al. (2007) also found an 
increased risk of pancreatic cancer in a retrospective cohort of 125,576 Swedish males 
that were construction workers from 1978-1992.  They calculated a RR of 2.0 (CI=1.2-
3.3) compared with never users of tobacco (Luo et al., 2007). 
Several case-control studies have found ST users have comparable or very 
slightly increased risk of developing heart disease to never-users of ST, but the studies 
have not been of large enough scale to confidently conclude that ST users experience no 
increased risk over never-users (Huhtasaari, Lundberg, Eliasson, Janlert & Asplund 
(1999).  A handful of studies have found a moderately increased risk for cardiovascular 
mortality, but there are fewer of these studies than studies finding no increased risk or 
even a slightly decreased risk of cardiovascular mortality in ST users compared to never-
users (Bolinder, Alfredsson, Englund, & de Faire, 1994).  Regardless of the impact ST 
has on risk of cardiovascular mortality compared to never-users, researchers do agree that 
ST confers a significantly smaller risk of a fatal cardiovascular event than does smoking 
(Asplund, 2003).   
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Despite the findings of the aforementioned studies, there are a small but 
significant number of researchers that believe ST is definitely not as bad as smoking and 
its health effects should be re-evaluated taking modern studies and improved ST 
manufacturing methods into account (Rodu & Cole, 2002, Waterbor et al., 2004, Rodu 
2011, Kozlowski 2007, Gartner & Hall, 2010).  There are also those in the public health 
field that are unwilling to openly admit any form of tobacco is less harmful, but are 
willing to consider the possibility (Hatsukami, Lemmonds, & Tomar, 2004, Mejia, Ling, 
& Glantz, 2010).   
The prevailing school of thought is based on research collected and published by 
the Surgeon General in a report on the health effects of ST in 1986 (Health, 1986), and 
more specifically, on the aforementioned paper published in 1981 by Winn et al that 
found a 50-fold increased risk of a particular type of oral cancer associated with dry snuff 
in long-term (>50 years) female dry snuff users that used the product an average of 21 
hours per day for 50 years or more (Winn et al., 1981).   
A recent and extensive meta-analysis found little to no statistically significant 
correlation between ST and cancer, though the meta-analysis was funded by the 
European Smokeless Tobacco Council (Lee & Hamling, 2009).  Lee & Hamling (2009) 
performed a meta-analysis of 62 American and 18 Scandinavian studies and found 
statistically significant increased risks only for oropharyngeal (OR 1.36 CI=1.04-1.77, 
n=19) and prostate (OR 1.29 CI=1.07-1.55, n=4) cancers; though the association between 
ST and oropharyngeal cancer disappeared in studies published since 1990 (OR 1.00 
CI=0.83-1.20, n=14), and in studies that adjusted for alcohol (OR 1.07 CI=0.84-1.37, 
n=10).  Lee & Hamling (2009) also calculated that of 142,205 smoking-related male 
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deaths in 2005, 1,102 (1.1%) would have been attributable to ST if as many men used ST 
as smoked, and 2,081 (2.0%) if every man had used ST instead of smoking.   
In the same year, Lee & Hamling (also 2009) published a commentary on the 
differences in RR estimates reported by Boffetta et al. in their 2008 study and Lee & 
Hamling’s own meta-analysis.  The two analyses appeared to contain very similar bodies 
of research, but Lee & Hamling found significantly lower RR estimates than Boffetta and 
his colleagues did for ST use overall and several different cancer sites.  Lee & Hamling 
(2009) used pre-defined criteria and included all studies that met the inclusion criteria 
(Boffetta et al. did not), as well as reporting separate RR estimates with studies that 
adjusted for smoking and those that did not (Boffetta et al did not).  Using the same 
studies as Boffetta et al. (2008), Lee & Hamling (2009) found estimated RR increases of 
<15% for esophageal, pancreatic, and lung cancers (Boffetta et al. found a non-significant 
increased risk of <20% for lung cancer and found statistically significant increased risks 
of 60-80% for esophageal, pancreatic, and oral cancers), and an increase of 36% for oral 
cancer.   
These findings suggest there has been some publication bias in the field of ST 
research.  When all applicable studies are considered, the purported increased risk of 
developing cancer due to ST use possibly approaches that of never-users of ST, though 
this is controversial at best.  The oft-reported 50-fold increased risk taken of oral cancer 
from Winn et al. (1981) also approaches that of non-users when only studies performed 
since 1990 are considered; this also is indicative of either shoddy epidemiology or some 
sort of bias, but influence from the tobacco industry cannot be entirely ruled out in some 
recent studies.  Though older studies found significantly increased risk for developing 
  
Farrey 13 
 
cancer with ST use, newer studies and meta-analyses have found minimal or no increased 
risk of oral cancer, other forms of head and neck cancer, or pancreatic cancer (Rodu & 
Cole, 2002, Bouquot & Meckstroth, 1998, Weitkunat, Sanders, & Lee, 2007).  More 
research is needed to more conclusively determine the risks of ST use; though in the 
meantime, professional and amateur baseball players alike will likely continue to use ST 
regardless of the potential health risks. 
 
2.3 ST Use in Baseball 
Smokeless tobacco (ST) and professional baseball, Major League Baseball 
(MLB), have been almost synonymous for over a century.  ST was first used in 
professional baseball to keep the player’s mouths moist during games as fields were 
significantly dustier than present fields (Eaves, 2011).  Even after fields became 
professionally groomed, the practice of using ST during baseball games continued.  
Baseball offers the ideal environment for an ST user as the risk of physical injury or 
physical contact while playing baseball is comparatively low when other sports are 
considered.  Combined with the stopping and starting nature of baseball, this creates an 
environment where ST is accepted and even encouraged by peer reinforcement, 
superstition, and other ritualistic behavior unique to baseball.  In college athletes 
especially, this can translate to increased ST usage off the field (Eaves, 2011).   
At the end of the 19th century and the beginning of the 20th, using ST was not as 
uncommon or socially unacceptable as using ST now.  ST usage in the US used to be 
significantly higher; until 1918 it was the predominant form of tobacco use in the US 
(Boffetta et al., 2008).  After a decline in use due to the rise in cigarette smoking because 
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of the development of automated cigarette production, ST rose in popularity again during 
the 1960s and 1970s after the dangers of cigarette smoking became more apparent and 
publicly known (Boffetta et al., 2008).  It was during this period that ST companies began 
providing free ST to professional baseball teams and initiated an aggressive marketing 
campaign targeting professional baseball players (Eaves, 2011).   
The first epidemiological studies investigating the prevalence of ST usage in 
MLB and other levels of play began to appear during the next several decades.  Studies 
have shown that the prevalence of ST use appears to rise with age, or the longer a player 
has played baseball (from high school to college, from college to professional).  Davis et 
al. (1997) took a survey of 1200 male high school athletes and found that 21% chew 
tobacco and 18% used moist snuff.  Walsh, Ellison, Hilton, Chesney, & Ernster (2000) 
found that 15% of the surveyed California public school baseball players were current ST 
users, and 46% were considered “ever-users.”  These numbers are significantly higher 
than ST usage in high school age groups on the whole; Agaku, Vardavas, Ayo-Yusuf, 
Alpert, & Connolly (2013) reported that 7.1% (CI=5.5-8.6%) of 15-17 year-olds and 
10.1% (CI=7.4-12.8%) of all 18 year-olds surveyed reported using ST in 2011.  It is also 
possible that the numbers presented in studies of high school students are conservative; 
the data are potentially impacted by high school players more unwilling to admit to 
purchasing and using tobacco than college or professional populations because ST is 
illegal to purchase until age 18 and its use is unequivocally illegal in all high school 
sporting events.   
Studies of collegiate baseball players have found comparable or higher rates of ST 
use on baseball teams than in high school.  Gingiss & Gottlieb (1991) found 
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approximately 53% of varsity baseball players and 25.9% of intramural baseball players 
surveyed used either chewing tobacco or moist snuff.  Walsh, Hilton, Ernster, 
Masouredis, & Grady (1994) found that 52% of varsity collegiate baseball players 
surveyed in their study (N=1,328) were current users of ST, and 41% of these users 
initiated use in high school.  The NCAA National Study of Substance Use Trends Among 
NCAA Student-Athletes (2012) found that 41.5% of surveyed varsity collegiate baseball 
players used ST in 2005, and in 2009, 52.3% used ST (Bracken, 2013).  Additional recent 
studies are sparse and do not seem to be available, leaving a considerable gap in the ST 
literature for the last ten years. 
This scarcity has not been present for studies about ST use in professional 
baseball.  Studies about the prevalence of ST use and the health effects it has had on the 
players started being published in the mid 1980s.  A study administered during spring 
training in 1987 surveyed 265 players from seven different MLB teams and found that 
34% of players were current ST users (Connolly, Orleans, & Kogan, 1988).  Wisniewski 
and Bartolucci (1989) surveyed 528 MLB players on 25 of the 26 MLB teams during 
spring training the same year (1987) and reported that 46% were current ST users.  Other 
peer-reviewed literature from 1988-1997 found rates of ST usage of 44%, 40%, 35%, 
41%, and 35% respectively, in samples of MLB players (Ernster et al., 1990, Green et al., 
1992, Green, Walsh, & Masouredis, 1994).  
 More recent studies have found encouraging results compared to the studies in the 
late 80s and 90s.  Sinusas and Coroso (2006) found a marked decrease in the overall 
prevalence of ST use in a sample of Major League Baseball players over a ten year period 
(1991-2000), from 41.1% in the first year to 25.6% in the tenth year.  Another six year-
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long study from 1998-2003 found MLB players’ self-reported ST use drop from 31.7% in 
1998 to 24.8% in 2003 (Severson et al., 2005).  Over time it seems the campaigns to 
reduce tobacco use in the professional baseball ranks have been somewhat successful, 
though ST usage rates in the MLB are still far too high.   
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Chapter III 
 
METHODS AND PROCEDURES  
 
 
3.1 Context and Rationale of Study 
 There are a multitude of studies about ST use in baseball at the professional level, 
but there are relatively few studies about ST use in baseball at the collegiate level.  ST in 
general, needs far more research before an educated view about its health effects can be 
made, and baseball teams provide a population that is likely to contain a sizable 
percentage of ST users.  The purpose of this study is to add to the small body of research 
about the prevalence of ST use in collegiate baseball.   
 
3.2 Study Instrumentation and Study Population 
 After obtaining Institutional Review Board approval from Georgia State 
University (GSU) and Oglethorpe University (OU), the attached survey (see Appendix A) 
about ST use was administered online to volunteer participants from GSU’s varsity 
baseball team and OU’s varsity baseball team, along with a waiver of documentation of 
consent (see Appendix B).  The survey was written by the author, with input from his 
thesis advisor and is based on his personal experience in collegiate baseball. It is 
designed to investigate patterns, origins, and cultural norms of ST use in collegiate 
baseball.  It consists of 26 items, and was administered on Qualtrics’ website 
(Qualtrics.com) and a unique link to the team’s respective survey was sent to each player.  
Participation was voluntary and anonymous, and the data obtained from both GSU 
players and OU players was hosted on secure, off-campus servers, and were tallied and 
examined separately, before being combined into a single data set for analysis.   
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  Both surveys were activated on October 29, 2013.  Players from both teams were 
given approximately three months to complete the survey during which time a school-
specific email invitation (see Appendix C) and two reminders to complete the survey 
were sent.  On February 1st, the survey was closed and the data was compiled and 
analyzed. 
 
3.3 Study Measures 
 As this is a prevalence study, the main variables of interest are the demographic 
variables and whether or not survey respondents have ever used ST, and whether they 
consider themselves to be habitual users of ST.  The variables chosen indicate a rough 
estimate of the prevalence of ST use on each team along with common demographic 
characteristics.   
Age was defined as the present age of the survey participant at the time of the 
survey based on the participant’s answer to “How old are you?”  Race/Ethnicity was 
defined as the race indicated by survey participants on the question, “What ethnic group 
do you consider yourself to be a part of?”  Current year of NCAA athletic eligibility was 
defined as the survey participant’s indicated year of collegiate athletic eligibility on the 
question, “What is your current year of college eligibility?”  Under normal 
circumstances, student-athletes are given four years of athletic eligibility in which they 
can compete.  There can be a fifth or even sixth year granted due to injury or personal 
hardship.  This question was asked to determine if status or length of time within the 
baseball program impacted the likelihood of a player to use ST without factoring in age.  
The last demographic variable, Position player or pitcher, was determined by the survey 
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participant’s answer to the question, “Are you a position player or pitcher (if both, which 
do you consider to be your primary role)?”  Pitchers tend to have more downtime when 
compared to position players given the nature of their role in the game of baseball.  This 
question was asked to determine whether or not this added downtime had any impact on 
ST use.  The last variable that was focused on was Opinion of ST, which was defined as 
the survey participants’ answer to the question, “Does ST use bother or offend you in any 
way?” The variable question labels were altered so as to make statistical analysis more 
practical, and charts more readable, as shown below (Table 3.1).   
Table 3.1 Modified labels 
“How old are you?”  = Age 
“What ethnic group do you consider yourself a part of?” = Race/Ethnicity 
“What is your current year of college eligibility?” = Current year of eligibility 
“Are you a position player or pitcher (if both, which do you consider to be your 
primary role)? = Position player or pitcher 
“Does ST use bother or offend you in any way?” = Opinion of ST  
 
 “Have you ever used ST?” or ever-use of ST, was defined as having ever (even 
once) used ST under any circumstances and was indicated by the player’s answer to that 
survey question.  “Do you consider yourself to be a habitual ST user?” or Habitual ST 
use, was defined by the author as daily ST use or ST use on most days.  Habitual ST use 
was determined based on the player’s answer to that particular survey question.  
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3.4 Statistical Analysis 
 The data from Qualtric’s secure servers was downloaded and exported to SPSS 
(Statistical Package for the Social Sciences), where the statistical analysis was performed.  
Cross tabulations, frequency tables, and descriptive statistics were run to look for patterns 
of ST use on each team and any associations present between demographic variables and 
whether or not a respondent used ST.  During the analysis, Chi square tests with p values 
of 0.05 were utilized to determine statistical significance between groups, if applicable. 
Though assessing ST prevalence was the primary aim of the study, players were also 
assessed based on their opinions and attitudes about or towards ST use.  Player responses 
to the question “Does ST use bother or offend you in any way?” were compared by 
school, and Age, Race/Ethnicity, Current Year of College Eligibility, and Position Player 
or Pitcher as defined above were each run against “Have you ever used ST?” and “Do 
you consider yourself to be a habitual ST user?” These demographic measures compared 
to ST use, along with the prevalence of ST use were the primary interests of 
administering the survey.  The following section presents the aforementioned cross 
tabulations along with the pertinent Chi square values where applicable, though the full 
results from the survey can be found in Appendix E.   
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Chapter IV 
 
RESULTS 
 
The following section will describe the findings of this cross-sectional prevalence 
study and address the following research questions:   
 
4.1 Study Population 
In total, 31 varsity baseball players were contacted by email about the survey at 
GSU and 35 varsity baseball players were contacted about the survey at OU.  Player 
information was obtained from the student directory for each school respectively.  There 
were 9 responses from GSU, giving a 29% response rate, and 15 from OU, giving a 
42.85% response rate, though one survey from each school was incomplete and thus 
omitted from the analysis.   
 
4.2 Age and ever-use of ST 
 The age distribution was nearly uniform in OU survey respondents (Table 4.1).  
Of these respondents, 20-year-olds were the most likely to report ever-use of ST (66.7%), 
followed by participants that were 22 and older (50%).   There was no statistically 
significant association between any age and ever-use of ST in respondents from OU 
(Table 4.2) (χ=3.471, p=.482).  The age distribution of GSU survey respondents was less 
uniform (Table 4.1).  Like OU players, GSU 20-year-olds had the highest prevalence of 
ever-use of ST, with 100% of them reporting ever-use.  There was no age associated with 
an increased likelihood of being an ever-user of ST in GSU players either (Table 4.2) 
(χ=2.597, p=.627).  Overall, 11 survey respondents in total reported ever-use of ST, 
meaning 50% of the study population reported ever-use of ST. 
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4.3 Race/Ethnicity and ever-use of ST 
 All respondents from both schools identified themselves as White (14 from OU, 
eight from GSU, shown in Table 4.1).  35.7% of respondents from OU identified as ever-
users of ST and 75% of respondents from GSU identified as ever-users of ST.  There was 
not a valid Chi-Square value as Race/Ethnicity was a constant.  Overall, all 11 survey 
participants that reported ever-use of ST were White. 
 
 
4.4 Current year of eligibility and ever-use of ST 
 Three freshmen, four sophomores, two juniors, three seniors, and two other 
responded to the survey invitation from OU for a nearly even distribution. Players with 
fewer years of eligibility remaining were more likely to report ever-use of ST, with the 
exception of the “other” group (50% of sophomores, 50% of juniors, and 66.7% of 
seniors) (Table 4.1).  None of these values were statistically significant (Table 4.2) 
(χ=5.662, p=.229). 
 The distribution of year of eligibility was similar in survey respondents from 
GSU.  Like OU, the distribution of current years of eligibility in GSU respondents was 
very nearly uniform. Of the GSU players that responded, 50% of freshmen, 100% of 
sophomores, 100% of juniors, 0% of seniors, and 100% of others identified themselves as 
ever-users of ST at GSU (Table 4.1).  Like OU, there was not a statistically significant 
association present in GSU players (Table 4.2) (χ=2.597, p=.667).  Seven of the 11 total 
players that indicated ever-use of ST were juniors or above (Table 4.1).   
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4.5 Position player or pitcher and ever-use of ST 
 Ten survey respondents identified themselves as position players and four survey 
respondents identified themselves as pitchers from OU (Table 4.1).  Pitchers from OU 
were more likely to report ever-use of ST, with 30% of position players and 50% of 
pitchers identifying themselves as ever-users of ST.  Neither of these values was 
statistically significant (Table 4.2) (χ=.052, p=.819).  By comparison, five survey 
respondents from GSU identified themselves as position players and three survey 
respondents from GSU identified themselves as pitchers (Table 4.1).  Thus position 
players from GSU were more likely to report ever-use of ST; though pitchers were still 
very likely to report ever-use of ST as well (80% of position players and 66.7% of 
pitchers identified themselves as ever-users of ST).  There was not a statistically 
significant correlation in GSU players (Table 4.2) (χ=.637, p=.425).  Of the 11 total 
players that indicated ever-use of ST, more position players reported ever-use of ST than 
pitchers (seven versus four) (Table 4.1).   
 
Table 4.1 – Ever-use of ST by School   
 
 
GSU (n=8) OU (n=14) Total (N=22) 
N 
Percent of 
School 
N 
Percent of 
School 
N 
Percent of 
Total 
Age 
 
18 1 12.5% 0 0% 1 4.5% 
19 0 0% 1 7.1% 1 4.5% 
20 3 37.5% 2 14.3% 5 22.7% 
21 0 0% 1 7.1% 1 4.5% 
22 or older 2 25% 1 7.1% 3 13.6% 
Race 
 
  
Farrey 24 
 
White 6 75% 5 35.7% 11 50% 
Year of Athletic 
Eligibility 
 
Freshman 1 12.5% 0 0% 1 4.5% 
Sophomore 1 12.5% 2 14.3% 3 13.6% 
Junior 2 25% 1 7.1% 3 13.6% 
Senior 0 0% 2 14.3% 2 9.1% 
Other (Redshirted) 2 25% 0 0% 2 9.1% 
Position 
 
Position Player 4 50% 3 21.4% 7 31.7% 
Pitcher 2 25% 2 14.3% 4 18.2% 
 
 
Table 4.2 – Chi-Square Tests for Ever-use of ST 
All variables stratified 
by school 
Have you ever used ST? Value df Asymp. Sig. 
(2-sided) 
Age 
Yes Pearson Chi-Square 3.471 4 .482 
No Pearson Chi-Square 2.597 4 .627 
Current Year of 
Eligibility 
Yes Pearson Chi-Square 5.622 4 .229 
No Pearson Chi-Square 2.597 4 .627 
Position 
Yes Pearson Chi-Square .052 1 .819 
No Pearson Chi-Square .637 1 .425 
 
 
 
4.6 Age and habitual ST use 
 The differences in habitual use between the two teams were striking but not 
statistically significant.  OU players reported less habitual ST use than GSU players.  
There was one 20-year-old OU player and one OU player that was 22 or older that self-
identified as habitual ST users, giving OU players an overall rate of 14.3% (two out of 
14) for habitual ST use (Table 4.3).  Somewhat surprisingly, these values were not 
statistically significant (Table 4.4) (χ=.875, p=.646). 
 GSU players reported more habitual ST use than OU players.  Overall, 62.5% of 
GSU players that completed the survey reported habitual ST use, dwarfing the 14.3% of 
  
Farrey 25 
 
OU players reporting habitual ST use (Table 4.3).  Also surprising was the lack of a 
statistically significant association with GSU players (Table 4.4) (χ=6.0, p=.199). 
 20-year-olds reported more habitual use than any other age group.  Seven players 
total reported habitual use, while six players reported use, but not habitual use, leaving no 
observable patterns (Table 4.3). 
 
4.7 Race/Ethnicity and habitual ST use 
 Table 4.6 shows habitual ST use stratified by Race/Ethnicity on the two teams.  
All respondents from both teams that completed the survey self-identified as White.  As 
mentioned above, a far greater percentage of GSU players indicated habitual use; only 
14.3% of OU players compared to 62.5% of GSU players that completed the survey 
identified themselves as habitual ST users (Table 4.3).  Race/Ethnicity was a constant so 
Chi square values were not calculated. 
 
  
4.8 Current year of eligibility and habitual ST use 
There were only two OU players that reported habitual ST use out of the 14 players that 
completed the survey; a sophomore and a senior (Table 4.3).  This gave OU players a 
non-significant overall prevalence of habitual ST use of 14.3% (Table 4.4) χ=4.55, 
p=.337).  Of GSU players, one freshman, one sophomore, two juniors, and one player 
that had redshirted indicated habitual ST use (Table 4.3).  This gave GSU players an 
overall prevalence of 62.5%, much higher than the 14.3% reported by OU players.  There 
was not a statistically significant association present in GSU players either (Table 4.4) 
(χ=6.0, p=.199).  Overall, seven players indicated habitual ST use, and six indicated ever-
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use of ST.  There were not any perceivable patterns in Current year of eligibility when 
the teams were compared side by side, though sophomores and juniors were more likely 
to have reported habitual use than other classes. 
 
4.9 Position player or pitcher and habitual ST use 
 One OU position player out of ten that responded (10%) and one pitcher out of 
four that responded (25%) identified themselves as habitual ST users, meaning OU 
pitchers were more likely to report habitual ST use than position players, albeit not by a 
large or statistically significant margin  (Table 4.4) (χ=.058, p=.809).  Three out of five of 
GSU position players (60%) that responded and two out of three GSU pitchers (66.7%) 
identified themselves as habitual ST users, meaning GSU pitchers were slightly more 
likely to report habitual ST use than position players (Table 4.3).  There was not a 
statistically significant association present in GSU players either (Table 4.4) (χ=.600, 
p=.439).  Between both teams, one more position player than pitcher reported habitual ST 
use, though there did not appear to be any perceptible patterns (Table 4.3). 
 
Table 4.3 – Habitual ST use by School 
 
 
GSU (n=8) OU (n=14) Total (N=22) 
N 
Percent 
of School 
N 
Percent 
of School 
N 
Percent 
of Total 
Age  
18 1 12.5% 0 0% 1 4.5% 
19 0 0% 0 0% 0 0% 
20 3 37.5% 1 7.1% 4 18.2% 
21 0 0% 0 0% 0 0% 
22 or older 1 12.5% 1 7.1% 2 9.1% 
Race 
 White 5 62.5% 2 14.3% 7 31.8% 
Year of Athletic 
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Eligibility 
Freshman 1 12.5% 0 0% 1 4.5% 
Sophomore 1 12.5% 1 7.1% 2 9.1% 
Junior 2 25% 0 0% 2 9.1% 
Senior 0 0% 1 7.1% 1 4.5% 
Other (Redshirted) 1 12.5% 0 0% 1 4.5% 
Position 
  
Position Player 3 37.5% 1 7.1% 4 18.2% 
Pitcher 2 25% 1 7.1% 3 13.6% 
 
 
Table 4.4 – Chi-Square Tests for Habitual ST Use 
All variables stratified 
by school 
Have you ever used ST? Value df Asymp. Sig. 
(2-sided) 
Age 
Yes Pearson Chi-Square .875 2 .646 
No Pearson Chi-Square 6.000 4 .199 
Current Year of 
Eligibility 
Yes Pearson Chi-Square 4.550 4 .337 
No Pearson Chi-Square 6.000 4 .199 
Position 
Yes Pearson Chi-Square .058 1 .809 
No Pearson Chi-Square .600 1 .439 
 
 
 
4.10 School and opinion about ST 
GSU players were less likely to be bothered or offended by ST use than OU 
players.  87.5% of GSU players surveyed were not bothered or offended by ST use, while 
only 57.1% of OU players surveyed were not bothered or offended by ST use (Table 4.9).  
Overall, 68.2% of players surveyed from both schools were not bothered or offended by 
ST use, but there was not a statistically significant association present (χ=2.986, p=.225).   
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Table 4.9 School stratified by opinion about ST  
 
Does ST use bother or offend you in any way? * School Crosstabulation 
 School Total 
GSU OU 
Does ST use bother or 
offend you in any way? 
Yes 
Count 0 4 4 
% within School 0.0% 28.6% 18.2% 
Not Sure 
Count 1 2 3 
% within School 12.5% 14.3% 13.6% 
No 
Count 7 8 15 
% within School 87.5% 57.1% 68.2% 
Total 
Count 8 14 22 
% within School 100.0% 100.0% 100.0% 
 
Chi-Square Tests 
 Value df Asymp. Sig. (2-
sided) 
Pearson Chi-Square 2.986 2 .225 
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Chapter V 
DISCUSSION AND CONCLUSION 
 
5.1 Discussion of Research Questions 
 
How many players use ST on the NCAA Division I baseball team and how many 
players use ST on the NCAA Division III baseball team?  Does one team have more 
ST users proportionately than the other?  What percentage overall of each team 
uses ST? 
 The survey results showed that six out of eight players that responded from GSU 
have ever used ST, giving a prevalence rate of 75%, while only five out of 14 players that 
responded from OU used ST, giving a prevalence rate of 35.7%.  More players said they 
had ever used ST on the NCAA Division I baseball team both proportionately and in 
absolute terms than the NCAA Division III baseball team (6/8 versus 5/14).  The results 
were more polarized when habitual ST use was concerned; five out of eight (62.5%) 
players that responded from GSU identified themselves as habitual ST users, while only 
two out of 14 (14.3%) players that responded from OU identified themselves as habitual 
ST users.  Self-identified habitual ST use was far more likely and prevalent on the NCAA 
Division I baseball team than on the NCAA Division III baseball team, though the Chi 
square values did not indicate any statistically significant associations on either team. 
 The variables Age, Race/Ethnicity, Current year of collegiate eligibility, and 
Position player or pitcher were not statistically significantly associated with ever-use of 
ST or habitual use of ST.  While ST use can certainly begin during collegiate baseball, 
many players start before they come to college and continue during their collegiate 
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careers as well, which is why age was not expected to show a statistically significant 
association with either ever-use of ST or habitual use of ST.  Given the survey 
demographics, every player that responded from both teams identified themselves as 
White.  This is not surprising given the numbers of that particular racial group on both 
teams, but it was surprising that no Black players or Hispanic/Latino players responded at 
all.   
Year of collegiate eligibility was not associated with ever-use of ST or habitual 
use; this was interesting in that the older one gets, the more likely one is to use ST in 
competitive baseball.  It was expected that the higher rates of ST ever-use or ST habitual 
use on each team would have been present in juniors, seniors, or redshirt juniors/seniors.   
This was surprising because the Division III team was expected to have a higher 
percentage proportionately of ST users than the Division I team based on the author’s 
personal experience having played both NCAA Division I baseball and NCAA Division 
III baseball.  The data is likely misleading though, as the prevalence rate of ST use on the 
GSU, the NCAA Division I team is unlikely to be as high as 75%.  Had more players 
responded to the survey, the prevalence of ST use found on each team likely would have 
been much closer, while still being much higher than the prevalence rate of ST use in the 
general population. 
 
Are NCAA baseball players that play a particular position more likely to use ST? 
Position players from OU were somewhat less likely to have ever used ST (three 
out of 10; 30%) than pitchers (two out of four; 50%).  GSU position players on the other 
hand were somewhat more likely to have ever used ST (four out of five, 80%) than 
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pitchers (two out of three, 66.7%).  OU position players were less likely (one out of ten; 
10%) to self-identify as habitual ST users than pitchers (one out of four; 25%).  GSU 
position players (three out of five; 60%) and pitchers (two out of three; 66.7%) were 
comparably likely to self-identify as habitual ST users.  None of the Chi square values 
were statistically significant, but based on the player responses, position players appear to 
be somewhat more likely to have ever used ST and habitually use ST than pitchers.  This 
perception is certainly influenced by the small number of players that responded to the 
survey and the small sample size generally.  
These results were interesting because position players have substantially less 
downtime than pitchers, so it was thought that pitchers might be more likely to have used 
or habitually use ST.  Unless a pitcher is physically on the pitching mound, pitching in 
the game, he is more than likely sitting down watching on the bench or in the bullpen for 
hours at a time, with generally very little to do.  This would lead one to believe that 
pitchers might be more inclined to use ST, but according to the data collected from the 
OU and GSU players, that would not seem to be the case.   
 
How do the collected survey results compare to other NCAA athlete survey 
responses?  Do the baseball players on these two teams use ST more or less than 
other NCAA baseball players around the country? 
 The most recent available data collected by the NCAA is from 2009 and it 
reported that 27.2% of male student-athletes reported some form of ST use in the last 12 
months. If both genders of student-athletes are considered, 17.4% report ST use in the 
past 12 months.  When only baseball players are considered, 52.3% of NCAA student-
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athletes reported ST use in the past 12 months (Bracken 2013).  Based on this data, OU 
baseball players were less likely than other NCAA varsity baseball players to have used 
ST.  GSU baseball players were equally likely or even more likely to have used ST than 
other NCAA varsity baseball players.   
It should be noted that the NCAA asked about past 12 month use of ST, while this 
survey asked about ever-use, past 30 day use, and habitual use of ST. So when comparing 
the rates of ST use found in this survey, the rates of habitual ST use reported by GSU and 
OU were used for comparison with the past 12 month ST usage rates found in 2009 by 
the NCAA (see Study Strengths and Limitations below). 
 
How do the ST usage rates from the two surveyed teams compare to NCAA student-
athlete data from years past? 
 Previous NCAA student-athlete substance abuse studies (1997, 2001) have found 
lower rates than their most current study has (2009).  Overall ST use in all NCAA 
student-athletes was 22.5% in 1997, and fell to 17.4% in 2001. The NCAA Substance 
Abuse studies in 1997 and 2001 found that 45.6% and 41% of varsity collegiate baseball 
players reported ST use in the past 12 months respectively (NCAA, 1997, NCAA, 2001). 
Compared to the past two NCAA student-athlete substance abuse studies, overall student-
athlete ST use remained unchanged at 17.4%, but baseball-specific ST use rose to 52.3% 
in the 2009 study (Bracken, 2013).    
 GSU baseball players were more likely to use ST habitually than NCAA student-
athletes generally and baseball players specifically, on average than in the past studies in 
1997 in 2001.  OU baseball players were quite a bit less likely to use ST habitually than 
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NCAA student-athletes generally and baseball players specifically, on average than in the 
past studies in 1997 in 2001 as well.  As mentioned above, these NCAA surveys asked 
about past 12 month use, while this survey asked about ever-use, past 30 day use, and 
habitual use.  Subsequently, the rates of habitual ST use in GSU and OU players 
measured by this survey were used to compare with the past 12 month rates of ST use 
found in the previous two NCAA student-athlete substance abuse studies (See Study 
Strengths and Limitations below). 
 
5.2 Study Strengths and Limitations 
A very significant limitation of this study was that the sample size of this study 
was too small for the results to be statistically stable or significant.  There is a 
considerable possibility that some of the results were distorted given the small number of 
survey respondents.  The observed patterns in the data were likely not indicative of the 
overall prevalence rates of the two teams; GSU’s baseball team is unlikely to have as 
high a prevalence of ST use as was found in the survey, and OU’s baseball team is likely 
to have somewhat higher prevalence of ST use than was found in the survey. As 
measured by the survey, GSU’s baseball team was well above the national average for 
varsity collegiate baseball programs and OU’s baseball team was well below the national 
average for varsity collegiate baseball programs.  One survey response from each school 
was incomplete and omitted from the final analysis.  If these two responses had been 
completed they likely would have influenced the final results to an extent as well.  
Another limitation from the analysis is that the results are not generalizable to the 
general population.  This may be a strength of the study when considering collegiate 
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athletes or collegiate baseball players specifically, but those populations are not 
representative of the public. This data may help contribute to the relatively small pool of 
data on ST use in collegiate baseball players, and may be more accurate to an extent in 
the sense that players may feel more comfortable being honest about their ST habits to 
someone not affiliated specifically with the governing body of the sport they participate 
in, the NCAA.   
As mentioned above, an oversight regarding survey question design occurred; the 
NCAA Student-Athlete Substance Abuse studies asked all student-athletes whether they 
had used ST in the past 12 months, while the survey administered to GSU and OU 
players did not ask about past 12 month use.  Given the difference in the survey questions 
asked by this survey and by the NCAA, it was thought that the rates of Habitual ST use 
found by this study would most likely include the past 12 month interval chosen by the 
NCAA.  During the writing of this survey, past 12 month use was not an amount of time 
thought of as a relevant interval, as one-time users could very well be pooled with regular 
users, the demographic of concern when trying to measure the overall prevalence of this 
type of behavior.  Counting a player that tried ST one time in the fall while off season but 
did not continue to use it should not be considered the same as a player that used ST 
multiple times daily, like in the NCAA surveys. This survey asked about the two 
scenarios separately, meaning the results from each question were more specific.  Asking 
about past use in the last 12 months is useful for other substances; anabolic steroids, for 
example.  It was only after the fact that the difficulty in accurately comparing habitual 
use or past 30-day use to use in the last 12 months became apparent.  If the survey 
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utilized in this study was used again, past 12 month use of ST would be added as a 
question.   
  Another limitation is the lack of incentive to participate in the survey; more 
players would likely have responded to the survey invitations had there been a monetary 
reward or some other sort of reward attached to survey participation.  More players also 
might have responded if baseball was “in-season,” though this is unclear as baseball 
players practice year-round.  There is baseball in the fall, followed by “unofficial 
practices” in the winter, then the season beginning in the spring. 
 Lastly, there was a discrepancy in the survey data regarding ever-use and habitual 
use in OU players.  Two OU players changed their answer from never-use to some use, 
but not habitual use when asked about habitual use.  The different answers did not change 
the statistical significance, but should be noted nevertheless. 
 
5.3 Recommendations for Future Research 
In general, there should be more research on the long-term health effects of ST, 
but this research should strictly control for other risk factors of disease, include every 
study that meets the predefined inclusion criteria, and not attempt to fit data to support a 
preexisting belief about ST.  Researchers should at least consider the population effects 
of a large number of smokers switching to ST and the potential for different outcomes at 
the population level.  If a researcher was to follow collegiate baseball players that 
habitually used ST over the long-term, it might give the scientific community a study 
representative of the least serious health outcomes in a population since athletes tend to 
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be in far better physical shape than the rest of the population, and are potentially less 
likely to also use cigarettes concurrently. 
This study would have worked better on a far larger scale with many more teams, 
preferably in different geographic locations or even multiple teams in the same 
conference but different locations.  Far more survey participants are needed for the data 
to have the stability needed to be taken as representative of the collegiate baseball 
student-athlete population.  Repeating this survey with a good sample size would likely 
produce interesting results.  A viable sample size might be all of the Division I and 
Division III teams in Georgia, or all of the Division I teams in the NCAA Southeastern 
Conference compared to all of the Division I teams in the NCAA Pacific-12 Conference, 
along with two comparable conferences in Division III baseball, though an even larger 
sample size would be even better.   
  
5.4 Conclusion 
 ST and baseball have been associated with each other for over a century.  This 
proclivity to use ST filters down by age, beginning (at least in terms of what has been 
researched) in high school, continuing and increasing in college, and finally at the 
professional level in MLB, where all of these players likely learned about ST  use in the 
first place.  There has been a strong and vocal campaign against ST use in MLB and its 
affiliate minor leagues by a multitude of different parties, varying in strength from 
grassroots organizations all the way up to a discussion in congress.  The campaigns 
appear to have been somewhat successful, as rates of ST use in the MLB ranks have 
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fallen from 40-45% to 25.6% in the last two decades (Wisniewski & Bartolucci, 1989, 
Sinusas & Coroso, 2006).   
The trend does not appear in younger players; rates of ST use in amateur baseball 
players appear to rise with age.  Studies have shown high school baseball player ST use 
varied between 15-21% (Davis et al., 1997, Walsh et al., 2000).  Multiple studies have 
found rates of ST use in varsity collegiate baseball players that vary from between 50-
52% (Bracken, 2013, Gingiss & Gottlieb, 1991, Walsh et al., 1994).  The data collected 
from GSU and OU presented here fall on either side of the approximately 50% estimates; 
ever-use and habitual use is far higher on GSU, the NCAA Division I baseball team (75% 
& 62.5%, respectively), than on OU, the NCAA Division III baseball team (35.7% & 
14.3%, respectively).  These numbers are most certainly affected by the small sample size 
(GSU, N=8, OU, N=14) and that reduces their statistical power considerably, as it is not 
possible to definitively determine the prevalence of ST use on either team based on such 
a small sample.  Regardless of the true prevalence of ST use in the study population and 
in collegiate baseball on the whole, the best chance public health professionals have to 
potentially reduce the number of ST users in collegiate baseball is by continuing to 
discourage ST use in the MLB.  Then hopefully as more professional players quit or 
never begin using ST in the first place, the effect will seep down the skill levels so that it 
is no longer a major part of baseball culture. 
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Appendix A – OU IRB Approval 
 
 
 
 
 
 
Date: August 21, 2013 
To:       Andrew Farrey, Principal Investigator 
 Oglethorpe University 
From: Brad Stone, Ph.D., Chair 
 Oglethorpe University Institutional Review Board for Research with Human Participants 
Re: A comparison of smokeless tobacco usage (ST) in two NCAA baseball programs and the National 
College Health Assessment smokeless tobacco data 
 
Dear Mr. Farrey: 
 
 I am writing in regards to your study, “A comparison of smokeless tobacco usage (ST) in two 
NCAA baseball programs and the National College Health Assessment smokeless tobacco data,” for which 
you requested an expedited review.  My review of your proposal convinced me that your study involves no 
more than minimal risk to participants, no unreasonable deception, and no additional ethical concerns that 
would warrant a full board meeting.  Consequently, I approved the expedited review and proceeded to 
examine the proposed methodology, evaluating it vis-à-vis the ethical standards presented in the DHHS 
Federal Code of Regulations Title 45, Part 46, the Belmont Report, and the Office for Human Research 
Protections.   
 
 Based upon my review I concluded that your study poses minimal risk for participants, that your 
protocol is straightforward and involves no unreasonable deception, and that you have taken adequate steps 
to guarantee the confidentiality of all potential participants.   
 
 Based on the information you have provided, I am confident that your study meets or exceeds best 
practices in safeguarding the rights of human research participants.  I  hereby grant you permission to 
proceed with your study with the following conditions: (1) If you become aware of any unintended ethical 
problems with your study, you will contact the IRB immediately; (2) If someone files a formal complaint to 
you regarding your study, you will inform the IRB immediately; (3) Your written and verbal informed 
consents include a statement about to whom participants should report any questions or concerns about 
your study – first would be to you, then the chair of the IRB’s at Oglethorpe ; (4) If you intend to alter your 
methodology in a manner that might reasonably affect a matter of research ethics, you will first submit a 
proposal for the change(s) to the IRB; and (5) The permission granted is for one year – following which 
you may submit a request for extended approval if you would like to continue the study.  Once your study 
has concluded, the IRB would like a brief letter for our records that summarizes how the study concluded 
and attests to whether or not there were any complaints raised by participants during the study in order for 
us to comply with federal regulations.   
 
 I wish you well with your data collection and thank you for your well organized approval request 
form and accompanying materials.  If you have any questions or concerns, do not hesitate to contact me, 
Dr. Brad Stone. 
 
Sincerely, 
 
Dr. Brad Stone 
Chair, Oglethorpe University Institutional Review Board for Research with Human Participants 
Phone: 404-364-8344; Email: bstone@oglethorpe.edu 
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Appendix A continued - GSU IRB Approval 
Completed Submissions 
  
Study Status: Approved 
Principal Investigator: Sterling, Kymberle 
IRB Number: H14093 
Study Title: A comparison of smokeless tobacco (ST) use between two NCAA baseball 
programs 
Expiration Date: 11/12/2016  
  
 
Reference 
Number 
Request Type Review Board 
View 
Outcome 
Letters 
Review 
Process 
Meeting Date 
Review 
Outcome 
Date Received 
324217  
Initial Review 
Submission 
Form 
 
  
Initial 
Review 
Submission 
Form 
 
IRB 
Review 
Board 
Committee  
 
Exempt  11/21/2013  Approved  
09/09/2013 
12:00:00 
AM EDT  
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Appendix B – Documentation of Waiver of Consent 
Georgia State University 
School of Public Health 
Informed Consent  
Title:  A comparison of smokeless tobacco usage in two NCAA baseball programs 
 
Principal Investigator:  Dr. Kimberle Sterling, Andy Farrey 
 
I. Purpose:   
You are invited to participate in a research study.  The purpose of the study is to 
investigate and compare the patterns of and attitudes toward smokeless tobacco (dip) 
usage on an NCAA Division I baseball team and an NCAA Division III baseball team.  
You are invited to participate because you are a member of the varsity baseball team.  A 
total of approximately 40-50 participants will be recruited for this study between the two 
teams.  Participation will require 15 minutes of your time. 
 
II. Procedures:  
 
If you decide to participate, you will be asked to fill out a survey on Qualtrics’s 
website.  Qualtrics specializes in academic research surveys.  The survey may be 
taken anywhere you choose, but should be taken in a private place and you should 
close the browser window upon completing the survey. Please complete it by 
October 25, 2013. It is a one-time survey and you have no other obligations upon 
completing it.  You will not be asked to have any interaction with anyone as a part of 
the study.   
 
III. Risks:  
 
In this study, you will not have any more risks than you would in a normal day of 
life.  All possible steps will be taken to ensure the confidentiality of the data, and 
the data will be stored on a third party firewall-protected and encrypted server.   
 
IV. Benefits:  
 
Participation in this study may not benefit you personally. Overall, we hope to gain 
information about patterns of smokeless tobacco use on collegiate baseball teams.   
 
V. Voluntary Participation and Withdrawal:  
 
Participation in research is voluntary.  You do not have to be in this study.  If you 
decide to be in the study and change your mind, you have the right to drop out at any 
time.  You may skip questions or stop participating at any time.  Whatever you decide, 
there are no consequences. 
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VI. Confidentiality:  
 
We will keep your records private to the extent allowed by law.  Only the study’s 
Principal Investigator Dr. Kimberle Sterling and Student Investigator Andy Farrey will 
have access to the information you provide. Information may also be shared with those 
who make sure the study is done correctly (GSU Institutional Review Board, the Office 
for Human Research Protection (OHRP).  We will not ask for your name so it will not be 
on study records.  The information you provide will be stored on Qualtric’s firewall-
protected and encrypted servers under a strict privacy and security policy.  They are 
maintained by a third party that specializes in protecting sensitive data and are regularly 
checked for intrusions.  Please be aware that information sent over the internet might not 
be secure, but the only potentially personally identifying information will be your IP 
address and we will not collect that information.  Georgia State University will not have 
access to the survey data.  Any information that might point to you will not appear when 
we present this study or publish its results. The findings will be summarized and reported 
in group form. You will not be identified personally. 
 
VII.    Contact Persons:  
 
Contact Dr. Kimberle Sterling at 404-413-1129 or ksterling@gsu.edu or Andy Farrey at 678-
591-0079 or afarrey1@student.gsu.edu if you have questions, concerns, or complaints about 
this study. You can also call if you think you have been harmed by the study.  Call Susan 
Vogtner in the Georgia State University Office of Research Integrity at 404-413-3513 or 
svogtner1@gsu.edu if you want to talk to someone who is not part of the study team.  You 
can talk about questions, concerns, offer input, obtain information, or suggestions about the 
study.  You can also call Susan Vogtner if you have questions or concerns about your rights 
in this study.  
 
VIII. Copy of Consent Form to Subject:  
 
You may print a copy of the consent form for your records. 
 
If you are willing to volunteer for this research, please take the survey at your convenience 
by February 1, 2014.   
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Appendix C – Invitation Emails 
OU- 
Subject Line: Smokeless tobacco survey for Oglethorpe University baseball players  
 
Dear Oglethorpe University baseball player, 
 
You are invited to participate in an online survey as part of a research study.  You are 
receiving this email because you are listed on the varsity roster of the Oglethorpe 
University baseball team.  Your email address was obtained from the campus directory.   
 
The title of this study is, “A comparison of smokeless tobacco usage in two NCAA 
baseball programs and the National College Health Assessment smokeless tobacco data.” 
The Principal Investigator is Dr. Kimberle Sterling and the Principal Student Investigator is 
Andy Farrey.  
 
This study will look at the usage of smokeless tobacco on Oglethorpe University’s varsity 
baseball team and Georgia State University’s varsity baseball team.  It will attempt to 
examine patterns and frequency of smokeless tobacco use on each team, past history of 
smokeless tobacco use, and attitudes toward its use in users and non-users and compare 
those values to the National College Health Assessment measurements of smokeless 
tobacco use in comparable age groups that are not athlete-specific. 
 
This survey is voluntary and will take less than 15 minutes.  The data collected is 
confidential and will not be examined by anyone except Dr. Sterling and Andy Farrey, and 
names and IP addresses are not being recorded.  If you decide to participate, please read the 
attached waiver of documentation of consent, then click on the link below and complete the 
survey on Qualtric’s website.   
 
If you have questions, do not hesitate to contact Dr. Kimberle Sterling at 404-413-1129 or 
ksterling@gsu.edu, or Andy Farrey at 678-591-0079 or afarrey1@student.gsu.edu.     
 
Thank you! 
 
(Link) 
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GSU- 
Subject Line: Smokeless tobacco survey for Georgia State University baseball players  
 
Dear Georgia State University baseball player, 
 
You are invited to participate in an online survey as part of a research study.  You are 
receiving this email because you are listed on the varsity roster of the Georgia State 
University baseball team.  Your email address was obtained from the Campus Directory.   
 
The title of this study is, “A comparison of smokeless tobacco usage in two NCAA 
baseball programs and the National College Health Assessment smokeless tobacco data.” 
The Principal Investigator is Dr. Kimberle Sterling and the Principal Student Investigator is 
Andy Farrey.  
 
This study will look at the usage of smokeless tobacco on Georgia State University’s 
varsity baseball team and Oglethorpe University’s varsity baseball team.  It will attempt to 
examine patterns and frequency of smokeless tobacco use on each team, past history of 
smokeless tobacco use, and attitudes toward its use in users and non-users and compare 
those values to the National College Health Assessment measurements of smokeless 
tobacco use in comparable age groups that are not athlete-specific. 
 
This survey is voluntary and will take less than 15 minutes.  The data collected is 
confidential and will not be examined by anyone except Dr. Sterling and Andy Farrey, and 
names and IP addresses are not being recorded.  If you decide to participate, please read the 
attached waiver of documentation of consent, then click on the link below and complete the 
survey on Qualtric’s website.   
 
If you have questions, do not hesitate to contact Dr. Kimberle Sterling at 404-413-1129 or 
ksterling@gsu.edu, or Andy Farrey at 678-591-0079 or afarrey1@student.gsu.edu.     
 
Thank you! 
 
(Link) 
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Appendix D – Survey Instrument 
GSU – 
Smokeless Tobacco (ST) Use in Collegiate Baseball 
 Please answer the following questions.  I am a Master’s of Public Health 
candidate at Georgia State University and I am collecting data for my thesis about use of 
ST in collegiate baseball.  I am looking for patterns of use and will compare this data to 
an identical survey given at Oglethorpe University to their baseball program.  If you have 
any questions feel free to email me at afarrey11@yahoo.com.  Information obtained from 
this survey is completely confidential, and participation is voluntary.  Please complete 
the survey in a private environment and close the browser window when finished.  Please 
answer honestly.   
 
 
HISTORY OF SMOKELESS TOBACCO (ST) USE 
1. Have you ever used ST?  
a. Yes 
b. No 
 
2. How long have you been using ST? 
a. I have never used ST 
b. 6 months or less 
c. 7 months to a year 
d. A year or two 
e. More than two years 
Other: ____________ 
 
3. Have you used ST at least once in the past 30 days? 
a. I have never used ST 
b. Yes 
c. No 
 
4. Would you classify yourself as a “dipper?”  A “dipper” is defined as 
someone who uses ST often or regularly.  
a. I have never used ST 
b. Yes 
c. No 
d. Maybe/Not Sure 
 
5. Do you consider yourself to be a habitual (daily use or use on most days) 
ST user? 
a. I have never used ST 
b. Yes 
c. No 
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6. Within the last 30 days, on how many days did you use ST?? 
a. I have never used ST 
b. Have used, but not in the last 30 days 
c. 1-2 days 
d. 3-5 days 
e. 6-9 days 
f. 10-19 days 
g. 20-29 days 
h. All 30 days 
 
7. If you use ST regularly, how long does it take you to finish one can? 
a. I have never used ST 
b. I do not use enough to buy my own cans 
c. <1 day 
d. 1-2 days 
e. 3-5 days 
f. 6-9 days 
g. 10-19 days 
h. 20-29 days 
i. All 30 days 
 
BRANDS AND TYPES OF ST USE 
1. What type of ST do you use/prefer? 
a. I have never used ST 
b. Long cut 
c. Fine cut 
d. Snuff 
e. Whole leaves- “chew” 
f. Pouches 
g. Snus 
 
2. What brand of ST do you typically use?   
a. Skoal/Copenhagen 
b. Grizzly/Kodiak 
c. Timberwolf 
d. Red Man/Beech-nut 
e. Redwood/Kayak 
f. Marlboro/Camel/Triumph/Skoal Snus 
g. Other:_________ 
 
BASEBALL AND ST USE 
1. At what types of baseball events do you typically use ST? 
a. I do not use ST 
b. At practices and games 
c. At practices only 
d. At games only 
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2. Is there a team policy about ST?  This could be from coaches, training 
staff, etc. 
a. Yes 
b. No 
c. Not Sure 
d. Yes but not enforced 
 
3. Have you ever heard of or seen any disciplinary actions taken against any 
player because of ST use? 
a. Yes 
b. No 
c. Not sure 
 
4. Does ST use bother you or offend you in any way? 
a. Yes 
b. No 
c. I’m indifferent to ST use 
 
5. Has a teammate (on any team) ever offered ST to you? 
a. Yes 
b. No 
c. Not Sure 
 
6. Has a coach (on any team) ever offered ST to you? 
a. Yes 
b. No 
c. Not Sure 
 
7. Is ST use part of your college baseball team’s culture?  Specifically, is 
there ST use on the field, at parties, meetings, etc.?  Please circle all that apply. 
a. On field (games and practices) 
b. Just practices 
c. Just games 
d. At team meetings 
e. At parties/just hanging out 
f. No 
g. Other: ____________ 
 
8. Do the coaches of your current baseball team care about player ST use? 
a. Yes 
b. No 
c. Not sure/Hadn’t noticed 
d. They know about it but don’t mention it 
e. They use it too 
f. Other: ___________________________ 
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9. Does the NCAA ban on ST affect your ST use? 
a. I do not use ST 
b. Yes 
c. No 
d. Hadn’t thought about it 
 
 
ST PRACTICES AND BELIEFS ABOUT ST USE 
1. Are you secretive about your ST use? 
a. I do not use ST 
b. Yes 
c. No 
d. Never thought about it 
 
2. Are you concerned about the long-term risk often associated with ST? 
a. Yes 
b. No 
c. Hadn’t thought of it 
 
3. Are you concerned about the long-term risk associated with tobacco use 
generally? 
a. Yes 
b. No 
c. Hadn’t thought of it 
 
4. Do you consider your oral hygiene more important because you use ST?  
As in do you make sure to brush your teeth more frequently than you might 
otherwise since you use ST? 
a. I do not use ST 
b. Yes 
c. No 
d. Not Sure/Hadn’t thought about it 
 
DEMOGRAPHIC INFORMATION 
1. How old are you? 
a. 18 
b. 19 
c. 20 
d. 21 
e. 22 or older 
 
2. What ethnic group do you consider yourself a part of? 
a. White 
b. Black 
c. Hispanic/Latino 
d. Asian 
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e. Other: _________________ 
 
3. What is your current year of college eligibility? 
a. Freshman 
b. Sophomore 
c. Junior 
d. Senior 
e. Other: __________________ 
 
4. Are you a position player or a pitcher (If both, which do you consider your 
primary role)? 
a. Position player 
b. Pitcher 
c. Decline to answer 
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OU- 
Smokeless Tobacco (ST) Use in Collegiate Baseball 
 Please answer the following questions.  I am a Master’s of Public Health 
candidate at Georgia State University and I am collecting data for my thesis about use of 
ST in collegiate baseball.  I am looking for patterns of use and will compare this data to 
an identical survey given at Georgia State University to their baseball program.  If you 
have any questions feel free to email me at afarrey11@yahoo.com.  Information obtained 
from this survey is completely confidential, and participation is voluntary.  Please 
complete the survey in a private environment and close the browser window when 
finished.  Please answer honestly.   
 
 
HISTORY OF SMOKELESS TOBACCO (ST) USE 
1. Have you ever used ST?  
a. Yes 
b. No 
 
2. How long have you been using ST? 
a. I have never used ST 
b. 6 months or less 
c. 7 months to a year 
d. A year or two 
e. More than two years 
Other: ____________ 
 
3. Have you used ST at least once in the past 30 days? 
a. I have never used ST 
b. Yes 
c. No 
 
4. Would you classify yourself as a “dipper?”  A “dipper” is defined as 
someone who uses ST often or regularly.  
a. I have never used ST 
b. Yes 
c. No 
d. Maybe/Not Sure 
 
5. Do you consider yourself to be a habitual (daily use or use on most days) 
ST user? 
a. I have never used ST 
b. Yes 
c. No 
 
6. Within the last 30 days, on how many days did you use ST?? 
a. I have never used ST 
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b. Have used, but not in the last 30 days 
c. 1-2 days 
d. 3-5 days 
e. 6-9 days 
f. 10-19 days 
g. 20-29 days 
h. All 30 days 
 
7. If you use ST regularly, how long does it take you to finish one can? 
a. I have never used ST 
b. I do not use enough to buy my own cans 
c. <1 day 
d. 1-2 days 
e. 3-5 days 
f. 6-9 days 
g. 10-19 days 
h. 20-29 days 
i. All 30 days 
 
BRANDS AND TYPES OF ST USE 
1. What type of ST do you use/prefer? 
a. I have never used ST 
b. Long cut 
c. Fine cut 
d. Snuff 
e. Whole leaves- “chew” 
f. Pouches 
g. Snus 
 
2. What brand of ST do you typically use?   
a. Skoal/Copenhagen 
b. Grizzly/Kodiak 
c. Timberwolf 
d. Red Man/Beech-nut 
e. Redwood/Kayak 
f. Marlboro/Camel/Triumph/Skoal Snus 
g. Other:_________ 
 
BASEBALL AND ST USE 
1. At what types of baseball events do you typically use ST? 
a. I do not use ST 
b. At practices and games 
c. At practices only 
d. At games only 
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2. Is there a team policy about ST?  This could be from coaches, training 
staff, etc. 
a. Yes 
b. No 
c. Not Sure 
d. Yes but not enforced 
 
3. Have you ever heard of or seen any disciplinary actions taken against any 
player because of ST use? 
a. Yes 
b. No 
c. Not sure 
 
4. Does ST use bother you or offend you in any way? 
a. Yes 
b. No 
c. I’m indifferent to ST use 
 
5. Has a teammate (on any team) ever offered ST to you? 
a. Yes 
b. No 
c. Not Sure 
 
6. Has a coach (on any team) ever offered ST to you? 
a. Yes 
b. No 
c. Not Sure 
 
7. Is ST use part of your college baseball team’s culture?  Specifically, is 
there ST use on the field, at parties, meetings, etc.?  Please circle all that apply. 
a. On field (games and practices) 
b. Just practices 
c. Just games 
d. At team meetings 
e. At parties/just hanging out 
f. No 
g. Other: ____________ 
 
8. Do the coaches of your current baseball team care about player ST use? 
a. Yes 
b. No 
c. Not sure/Hadn’t noticed 
d. They know about it but don’t mention it 
e. They use it too 
f. Other: ___________________________ 
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9. Does the NCAA ban on ST affect your ST use? 
a. I do not use ST 
b. Yes 
c. No 
d. Hadn’t thought about it 
 
ST PRACTICES AND BELIEFS ABOUT ST USE 
1. Are you secretive about your ST use? 
a. I do not use ST 
b. Yes 
c. No 
d. Never thought about it 
 
2. Are you concerned about the long-term risk often associated with ST? 
a. Yes 
b. No 
c. Hadn’t thought of it 
 
3. Are you concerned about the long-term risk associated with tobacco use 
generally? 
a. Yes 
b. No 
c. Hadn’t thought of it 
 
4. Do you consider your oral hygiene more important because you use ST?  
As in do you make sure to brush your teeth more frequently than you might 
otherwise since you use ST? 
a. I do not use ST 
b. Yes 
c. No 
d. Not Sure/Hadn’t thought about it 
 
DEMOGRAPHIC INFORMATION 
1. How old are you? 
a. 18 
b. 19 
c. 20 
d. 21 
e. 22 or older 
 
2. What ethnic group do you consider yourself a part of? 
a. White 
b. Black 
c. Hispanic/Latino 
d. Asian 
e. Other: _________________ 
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3. What is your current year of college eligibility? 
a. Freshman 
b. Sophomore 
c. Junior 
d. Senior 
e. Other: __________________ 
 
4. Are you a position player or a pitcher (If both, which do you consider your 
primary role)? 
a. Position player 
b. Pitcher 
c. Decline to answer 
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Appendix E – Full Survey Results 
 
Table of Demographics, History of ST Use, and Brands/Types of ST Use 
DEMOGRAPHICS 
 School Total 
N=22/% of 
Total 
GSU 
N=8; % of GSU 
OU 
N=14; % of OU  
Age 
18 Count / % 2 25% 3 21.4% 5  22.7% 
19 Count / % 0 0% 3 21.4% 3 3.6% 
20 Count / % 3 37.5% 3 21.4% 6 77.3% 
21 Count / % 0 0% 3 21.4% 3 13.6% 
22 or older Count / % 3 37.5% 2 14.3% 5 22.7% 
Race/Ethnic Group White Count / % 8 100% 14 100% 22 100.0% 
Current Year of 
Athletic Eligibility 
Freshman Count / % 2 25% 3 21.4% 5 22.7% 
Sophomore Count / % 1 12.5% 4 28.6% 5 22.7% 
Junior Count / % 2 25% 2 14.3% 4 18.2% 
Senior Count / % 1 12.5% 3 21.4% 4 18.2% 
Other (Red-shirted 
for example) 
Count / % 2 25% 2 14.3% 4 18.2% 
Position Player or 
Pitcher 
Position player Count / % 5 62.5% 10 71.4% 15 68.2% 
Pitcher Count / % 3 37.5% 4 28.6% 7 31.8% 
HISTORY OF ST USE 
Have you ever used 
ST? 
Yes Count / % 6 75% 5 35.7% 11 50% 
No Count / % 2 25% 9 64.3% 11 50% 
How long have you 
been using ST? 
I have never used ST Count / % 2 25% 9 64.3% 11 50% 
7 months to a year Count / % 0 0% 1 7.1% 1 4.5% 
A year or two Count / % 2 25% 1 7.1% 3 13.6% 
More than two years Count / % 4 50% 2 14.3% 6 27.3% 
Other Count / % 0 0% 1 7.1% 1 4.5% 
Have you used ST 
once in the past 30 
days? 
Yes Count / % 5 62.5% 2 14.3% 7 31.8% 
No Count / % 1 12.5% 5 35.7% 6 27.3% 
I have never used ST Count / % 2 25% 7 50% 9 40.9% 
Do you consider 
yourself to be a 
habitual (daily use or 
use on most days) 
ST user? 
Yes Count / % 5 62.5% 2 14.3% 7 31.8% 
No Count / % 1 12.5% 5 35.7% 6 27.3% 
I have never used ST Count / % 2 25% 7 50% 9 40.9% 
Within the last 30 I do not use ST Count / % 3 37.5% 9 64.4% 12 54.3% 
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days, on how many 
days did you use 
ST? 
Have used, but not in 
the last 30 days 
Count / % 0 0% 3 21.4% 3 13.6% 
20-29 Count / % 2 25% 0 0% 2 9.1% 
All 30 days Count / % 3 37.5% 2 14.3% 5 22.7% 
If you use ST 
regularly, how long 
does it take you to 
finish one can? 
I have never used ST Count / % 2 25% 9 64.3% 11 50% 
I do not use enough 
to buy my own cans 
Count / % 1 12.5% 2 14.3% 3 13.6% 
1-2 days Count / % 3 37.5% 1 7.1% 4 18.2% 
3-5 days Count / % 0 0% 1 7.1% 1 4.5% 
6-9 days Count / % 1 12.5% 0 0% 1 4.5% 
10-19 days Count / % 1 12.5% 1 7.1% 2 9.1% 
BRANDS AND TYPE OF ST USE 
What type of ST do 
you use/prefer? 
I do not use ST Count / % 3 37.5% 10 71.4% 13 59.1% 
Long cut Count / % 3 37.5% 4 28.6% 7 31.8% 
Pouches Count / % 2 25% 0 0% 2 9.2% 
What brand of ST do 
you typically use?  
I do not use ST Count / % 3 37.5% 10 71.4% 13 59.1% 
Copenhagen Count / % 2 25% 2 14.3% 4 18.2% 
Grizzly/Kodiak Count / % 3 37.5% 2 14.3% 5 22.7% 
 
 
Table of Baseball and ST Use 
BASEBALL AND ST USE 
 School Total 
N=22/% of 
Total 
GSU 
N=8; % of GSU 
OU 
N=14; % of OU 
At what types of 
baseball events do 
you typically use 
ST? 
I do not use ST Count / % 3 37.5% 10 71.4% 13 59.1% 
At practices and 
games 
Count / % 4 50% 3 21.4% 7 31.8% 
At practices only Count / % 1 12.5% 1 7.1% 2 9.1% 
Is there a team 
policy about ST? 
This could be from 
coaches, training 
staff, etc. 
Yes Count / % 2 25% 4 28.6% 6 27.3% 
No Count / % 0 0% 2 14.3% 2 9.1% 
Not sure Count / % 1 12.5% 2 14.3% 3 13.6% 
Yes, but not 
enforced 
Count / % 5 62.5% 6 42.9% 11 50% 
Have you ever 
heard of or seen 
Yes Count / % 0 0% 5 37.5% 5 22.7% 
No Count / % 8 100% 8 57.1% 16 72.7% 
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any disciplinary 
actions taken 
against any player 
because of ST use? 
Not sure Count 0 0% 1 7.1% 1 4.5% 
Does ST use bother 
or offend you in any 
way? 
Yes Count / % 0 0% 4 28.6% 4 18.2% 
Not Sure Count / % 1 12.5% 2 14.3% 3 13.6% 
No Count / % 7 87.5% 8 57.1% 15 68.2% 
Has a teammate (on 
any team) ever 
offered ST to you? 
Yes Count / % 8 100% 12 87.5% 20 90.9% 
Maybe Count / % 0 0% 1 7.1% 1 4.5% 
No Count / % 0 0% 1 7.1% 1 4.5% 
Has a coach (on 
any team) ever 
offered ST to you? 
Yes Count / % 2 25% 2 14.3% 4 18.2% 
No Count / % 5 62.5% 11 78.6% 16 72.7% 
Not sure Count / % 1 12.5% 1 7.1% 2 9.1% 
Is ST use part of 
your college 
baseball team’s 
culture?   
On field  (games/ 
practices) 
Count / % 6 75% 12 87.5% 18 81.8% 
Just Practices Count / % 1 12.5% 2 14.3% 3 13.6% 
Just Games Count / % 0 0% 0 0% 0 0% 
At team meetings/ 
functions 
Count / % 5 62.5% 8 8 13 59.1% 
At parties/ just 
hanging out 
Count / % 7 87.5% 11 57.1% 18 81.8% 
No Count / % 1 12.5% 1 7.1% 2 9.1% 
Other Count / % 1 12.5% 1 7.1% 2 9.1% 
Do your current 
coaches care about 
player ST use 
personally? 
No Count / % 2 25% 8 57.1% 10 45.5% 
Not sure/Hadn't 
noticed 
Count / % 2 25% 3 21.4% 5 22.7% 
They know about it 
but don't mention it 
Count / % 2 25% 3 21.4% 5 22.7% 
They use it too Count / % 2 25% 0 0% 2 9.1% 
Does the NCAA ban 
on ST affect your ST 
use? 
I do not use ST Count / % 3 37.5% 10 71.4% 13 59.1% 
Yes Count / % 1 12.5% 0 0% 1 4.5% 
No Count / % 4 50% 3 21.4% 7 31.8% 
Hadn't thought about 
it 
Count / % 0 0% 1 7.1% 1 4.5% 
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Table of ST Practices and Beliefs about ST Use 
ST PRACTICES AND BELIEFS ABOUT ST USE 
 School Total 
N=22/% of 
Total 
GSU 
N=8; % of GSU 
OU 
N=14; % of OU 
Are you secretive 
about your ST use? 
I do not use ST Count / % 3 37.5% 10 71.4% 13 59.1% 
Yes Count / % 1 12.5% 0 0% 1 4.5% 
Only during 
games/practices 
Count /% 1 12.5% 0 0% 1 4.5% 
No Count / % 3 37.5% 4 28.6% 7 31.8% 
Are you concerned 
about the possible 
long-term health 
risks associated with 
ST? 
I do not use ST Count / % 3 37.5% 10 71.4% 13 59.1% 
Yes Count / % 3 37.5% 2 14.3% 5 22.7% 
No Count / % 0 0% 1 7.1% 1 4.5% 
Hadn't thought 
about it 
Count / % 2 25% 1 7.1% 3 13.6% 
Are you concerned 
about the long-term 
health risks 
associated with 
tobacco generally? 
I do not use ST Count / % 3 37.5% 10 71.4% 13 59.1% 
Yes Count / % 4 50% 4 28.6% 8 36.4% 
Hadn't thought 
about it 
Count / % 1 12.5% 0 0% 1 4.5% 
Do you consider 
your oral hygiene 
more important 
because you use 
ST? 
I do not use ST Count / % 3 37.5% 10 71.4$ 13 59.1% 
Yes Count / % 4 50% 2 14.3% 6 27.3% 
No Count / % 0 0% 1 7.1% 1 4.5% 
Hadn't thought 
about it 
Count / % 1 12.5% 1 7.1% 2 9.1% 
 
 
 
 
 
 
 
 
 
 
 
